PNKC is a questionable neurological disorder with complex clinical performance that often involves multiple systemic burdens. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of PNKC requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of PNKC for seizure-induced non-motion inductive movement disorder. The platform serves a team of internationally authoritative experts in the field of neural systems related to the International Medical Service System of China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.